An estimated 1 in 3 Canadian women will have an abortion during her lifetime, most commonly performed during the first trimester of pregnancy. However, Canadian women lack access to a safe, effective and often preferred method of early abortion that is available in many other countries. The internationally recognized "gold standard" for medical (i.e., nonsurgical) abortion, mifepristone (followed by misoprostol), is not available in Canada.
Making mifepristone available in Canada
Tuesday, November 26, 2013
Dr. Sheila Dunn and Dr. Rebecca Cook have published an article in the Canadian Medical Association Journal arguing that Health Canada should approve mifepristone in Canada. See an article on the subject in the Ottawa Citizen. An extract of the paper is available here. A short excerpt:
Designed by Rachel Gold.